A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2004
12/01/2004	EP1481011A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
12/01/2004	EP1481009A2 Peptides for use in antitumor immunotherapy
12/01/2004	EP1481008A2 Anti-amyloid beta antibodies and their use
12/01/2004	EP1481007A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom
12/01/2004	EP1481006A2 Universal antimicrobial treatment
12/01/2004	EP1481003A2 Hsp70-derived peptides an uses thereof in the diagnosis and treatment of autoimmune diseases
12/01/2004	EP1480997A2 Haemophilus adherence and penetration proteins
12/01/2004	EP1480682A1 Coupling proteins to a modified polysaccharide
12/01/2004	EP1480674A1 Treatment of central nervous system damage
12/01/2004	EP1480671A2 Recombinant rsv virus expression systems and vaccines
12/01/2004	EP1480670A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
12/01/2004	EP1480666A2 Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
12/01/2004	EP1480660A2 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
12/01/2004	EP1480656A1 Hyaluronic acid mediated adenoviral transduction
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1480548A2 Targeting of a systemically generated immune response to a specific organ or tissue
12/01/2004	EP1480520A2 Human fetal bladder-derived epithelial cells
12/01/2004	EP1480519A1 Re-activated t-cells for adoptive immunotherapy
12/01/2004	EP1257584B9 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1189631B1 Neurodegenerative disorder related gene
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1073745B1 Immunization against and treatment for infection by h. pylori
12/01/2004	EP0912611B9 Human monoclonal antibodies to the hepatitis b surface antigen
12/01/2004	EP0895537B1 Iga1 protease fragment as carrier peptide
12/01/2004	EP0845540B1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
12/01/2004	EP0551401B2 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004	CN1551913A Infectious bovine viral diarrhea virus clone and production method and use
12/01/2004	CN1551888A Modified human growth hormone
12/01/2004	CN1551886A Specific human antibodies for selective cancer therapy
12/01/2004	CN1551783A Method for treating multiple myeloma
12/01/2004	CN1551782A Chimeric flavivirus vectors
12/01/2004	CN1551781A One dose vaccination with mycoplasma hyopneumoniae
12/01/2004	CN1550236A Protein stability in aqueous solution
12/01/2004	CN1550235A Use of heparin-binding antagonists in the inhibition of bradykinin release
12/01/2004	CN1177927C Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgruop B
12/01/2004	CN1177863C Attenuated microorganisms for treatment of infection
12/01/2004	CN1177610C Pharmaceutical composition for immunomodulation based on peptides and adjuvants
12/01/2004	CN1177581C Aqueous aerosol preparations containing biologically active macromolecules and method for producing the corresponding aerosols
11/2004
11/30/2004	US6825326 Antibody which specifically binds to prostate stem cell antigen on surface of carcinoma cells and is internalized within carcinoma cells to which it binds
11/30/2004	US6825324 Antibodies to receptor protein tyrosine kinases
11/30/2004	US6825318 Vaccine for obesity therapy; hybrid polypeptides
11/30/2004	US6825036 Genetically engineered cells for use as tool in the generation of vaccines
11/30/2004	US6825027 Method of production of purified hepatitis a virus particles and vaccine preparation
11/30/2004	US6825007 Therapeutic and diagnostic methods and compositions based on Jagged/Notch proteins and nucleic acids
11/30/2004	US6824993 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
11/30/2004	US6824992 Nucleotide sequences coding polypeptides for use in the treatment and prevention of infections
11/30/2004	US6824795 Synergystic mixtures of mint oils, terpenes and ajuvants used as bactericides
11/30/2004	US6824793 Bioadhesive properties of the hyaluronic acid polymers decrease the rate of mucociliary clearance from the nasal cavity and thus allow a longer contact time between the antigen and the absorbing membrane
11/30/2004	US6824784 Cold-adapted equine influenza viruses
11/30/2004	US6824783 Delaying the onset of aids in an hiv- 1 infected individual, comprising administering a peptide which inhibits membrane fusion-associated events, i.e. syncytia formation between hiv-1 infected cells and cells uninfected
11/30/2004	US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
11/30/2004	US6824773 TWEAK receptor
11/30/2004	CA2267072C Reconstituted human anti-hm1.24 antibody
11/30/2004	CA2144081C Protection against liver damage by hgf
11/25/2004	WO2004101795A1 Variable proteins of mycoplasma mycoides, vaccines and process thereof
11/25/2004	WO2004101780A2 Heparanase-derived peptides for vaccination of tumor patients
11/25/2004	WO2004101766A2 Grp94-based compositions and methods of use thereof
11/25/2004	WO2004101747A2 Identification and use of gpr54 and its ligands for reproductive disorders and contraception
11/25/2004	WO2004101745A2 NOVEL REGULATORY MECHANISMS OF NF-kappaB
11/25/2004	WO2004101740A2 Clotting factor-fc chimeric proteins to treat hemophilia
11/25/2004	WO2004101739A2 Methods for chemically synthesizing immunoglobulin chimeric proteins
11/25/2004	WO2004101737A2 A novel adjuvant capable of specifically activating the adaptive immune response
11/25/2004	WO2004101621A1 A SPECIFIC IMMUNOGLOBULIN (Ig) Y AGAINST SEVERVE ACUTE RTESPIRATORY SYNDROME (SARS) AND A PREPARING METHOD THEREOF AND COMBINATION PREPARATIOS CONTAINING IT
11/25/2004	WO2004101607A2 Comparative ligand mapping from mhc class i positive cells
11/25/2004	WO2004100987A2 Methods of using il-1 antagonists to treat neointimal hyperplasia
11/25/2004	WO2004100985A2 Materials and methods for immunizing against fiv infection
11/25/2004	WO2004100984A1 Endogenous adjuvant molecules and uses thereof
11/25/2004	WO2004100898A2 Therapeutic use of anti-cs1 antibodies
11/25/2004	WO2004100890A2 Rage g82s-related methods and compositions for treating inflammatory disorders
11/25/2004	WO2004100877A2 Vaccine accelerator factor (vaf) for poultry
11/25/2004	WO2004100870A2 Compositions and methods for wt1 specific immunotherapy
11/25/2004	WO2004100868A2 Method of treating transplant rejection
11/25/2004	WO2004100659A2 Dinoflagellate karlotoxins, methods of isolation and uses thereof
11/25/2004	WO2004100640A2 Marek’s disease virus vaccine
11/25/2004	WO2004085468A3 Human p53 splice variant displaying differential transcriptional activity
11/25/2004	WO2004078203A3 Infectious bronchitis virus with an altered spike gene
11/25/2004	WO2004072095A3 Cyclized peptides as exotoxin antagonists
11/25/2004	WO2004069272A3 Adjuvant combination for use in the immunization of a mamal comprising il2 and il12
11/25/2004	WO2004069204A3 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins
11/25/2004	WO2004067032A3 Identification of gene sequences and proteins involved in vaccinia virus dominant t cell epitopes
11/25/2004	WO2004065603A3 Methods for increasing neisseria protein expression
11/25/2004	WO2004064889A3 Intradermal cellular delivery using narrow gauge micro-cannula
11/25/2004	WO2004064738A3 Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
11/25/2004	WO2004053454A8 Methods for detecting invasion of a cell
11/25/2004	WO2004018635A3 Myxococcus xanthus bacteriophage mx9 transformation and integration system
11/25/2004	WO2003092479A3 Treatments and methods for the treatment, diagnosis and prophylaxis
11/25/2004	WO2003086280A3 Immunostimulatory g,u-containing oligoribonucleotides
11/25/2004	WO2003050260A3 Streptavidin expressed gene fusions and methods of use thereof
11/25/2004	WO2003038047A3 Human telomerase reverse transcriptase as a class-ii restricted tumor-associated antigen
11/25/2004	US20040237129 Transgenic rodent model for use in identifying modulators for treatment of cell proliferative disorders; antitumor agents; immunotherapy
11/25/2004	US20040237128 Transgenic non-human animal having a disruption of at least one allele to the ceacam 1 gene and method of making same
11/25/2004	US20040236093 Using chimeric dendritic cells comprising viral epitopes to generate vaccines to prevent and treat viral diseases
11/25/2004	US20040236087 Moraxella(branhamella) catarrhalis antigens
11/25/2004	US20040236082 Modified pyrogenic toxin for use in developing vaccine for prevention and treatment of toxic shock syndrome and food poisoning
11/25/2004	US20040236080 Particularly having antibody-dependent cell-mediated cytotoxicity activity or complement-dependent cytotoxicity activity, used for treating cancer
11/25/2004	US20040236076 Polyclonal IgY compound from eggs of transgenic SPF-chickens with constant regions of human IgG and additionally consist of at least one signal and/or active agent and/or booster molecule; for treating noninfectious inflammations, infectious diseases, clotting disorders, autoimmune diseases and cancer
11/25/2004	US20040236072 Immunogenic polynucleotides, polypeptides, and antibodies used for detecting, immunizing against, and reducing beta-hemolytic streptococcal infection
11/25/2004	US20040235785 Potentiator of antitumoral agents in the treatment of cancer
11/25/2004	US20040235778 Methods for regulating hematopoiesis using CpG-oligonucleotides

1 ... 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 ... 1823